Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Bhel 176.40 0.46
Tata Mot 423.15 2.91
Hindalco 138.30 2.18
Tcs Ltd 2203.95 0.41
Tata Stl 415.60 0.45
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Pfizer Limited
Pfizer Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500680NSE:PFIZERBloomberg:PFIZ@INReuters:PFIZ.BO
Market Lot: 1Face Value: 10ISIN Demat: INE182A01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
25-NOV-13 The board of the directors of Pfizer (`Pfizer India) and Wyeth (Wyeth India) in their respective meetings have approved a proposal to merge Wyeth India with Pfizer India. 25-NOV-13 Pfizer, the research-based pharmaceutical company, announced that the board of directors has approved the payment of interim dividend of Rs 360 equity share of Rs 10 each (3600%) to the shareholders of the company. The said interim dividend will be paid on...   More..
Business Profile Future Plans
One To One
Face To Face
We would like to grow above the market and have a whole lot of strategies. We are looking at alliances, brands, lucrative products, line extensions, new delivery systems  Kewal Handa ,finance director
Recent news
Latest News
Pfizer loses almost one-fourth of share value  -IRIS 05-Dec-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 7525.809479.8010173.00
Other Income930.701052.40905.60
Total Income8456.5010532.2011078.60
Cost of goods sold6717.008629.808966.20
OPBDIT1739.501902.402112.40
PAT1648.205032.001846.10
Gross Block---
Equity capital298.40298.40298.40
EPS (Rs.)-168.6361.87
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-5.92 - 8.3617.32 - 26.45
Debt / Equity (x)---
Operating margin (% of OI)20.618.119.1
Net margin (% of OI)19.547.816.7
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Pfizer Centre
Patel Estate
Off S V Road
Jogeshwari (West)
Mumbai
Maharashtra-400 102
PHONE
(022) 6693 2000
FAX
(022) 2678 4569
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer